Bronchial Artery Embolisation in Haemoptysis Management: A Scoping Review with Emphasis on Embolic Materials and Indications
Advances in Respiratory Medicine · 12.09.2025 · 93 (5) · 35
DOI: 10.3390/arm93050035 ↗Kurz gefasst
Scoping Review in der Zeitschrift Advances in Respiratory Medicine, online erschienen am 12.09.2025. Verfasst von Anna Ziętarska und 5 weiteren Autor:innen. Beteiligte Einrichtung: I Department of Radiology and Diagnostic Imaging, Norbert Barlicki Memorial Teaching Hospital No. 1, Medical University of Lodz, 90-153 Lodz, Poland. Hauptthemen laut MEDLINE: Hemoptysis, Embolization, Therapeutic, Bronchial Arteries. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lodz, Medical University of Łódź.
Abstract (Originalsprache)
Haemoptysis is an alarming symptom of a wide spectrum of underlying diseases, ranging from indolent chronic conditions to life-threatening states. Among the strategies to manage pulmonary bleeding is bronchial artery embolisation (BAE), an interventional radiology procedure. The objective of this scoping review was to map the current evidence on embolic agents used in BAE for haemoptysis management, with a focus on their clinical applications, and decision-making factors. Studies published between 2019 and 2024 were included if they specified the embolic material used and reported outcomes of BAE in adult patients. Data were extracted from PubMed and charted according to embolic agent type, recurrence rate, and clinical context. Thirty-one studies met the eligibility criteria. Polyvinyl alcohol (PVA) remains the most widely studied agent, comparable in efficacy to more homogeneous microspheres. Gelatin sponges (GS), though biodegradable, are well-documented and affordable, making them a common choice. N-butyl-2-cyanoacrylate (NBCA) is highly effective for small vessels and may offer lower recurrence rates. Coils are valuable in proximal embolisation and severe cases. This review highlights the need for individualised embolisation strategies and updated guidelines for material selection, considering clinical context, vascular anatomy, and recurrence rates. The findings aim to support evidence-based decision-making in interventional radiology practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- I Department of Radiology and Diagnostic Imaging, Norbert Barlicki Memorial Teaching Hospital No. 1, Medical University of Lodz, 90-153 Lodz, Poland.
- Department of Pneumology, Norbert Barlicki Memorial Teaching Hospital No. 1, Medical University of Lodz, 90-153 Lodz, Poland.
ORCID-Profile: Anna Ziętarska, Piotr Białek, Sebastian Majewski
Förderung
- Medical University of Lodz
- Medical University of Łódź
Zitieren
APA
Ziętarska, A., Dobek, A., Sawina, A., Białek, P., Majewski, S., & Stefańczyk, L. (2025). Bronchial Artery Embolisation in Haemoptysis Management: A Scoping Review with Emphasis on Embolic Materials and Indications. Advances in Respiratory Medicine, 93(5), 35. https://doi.org/10.3390/arm93050035
Vancouver
Ziętarska A, Dobek A, Sawina A, Białek P, Majewski S, Stefańczyk L. Bronchial Artery Embolisation in Haemoptysis Management: A Scoping Review with Emphasis on Embolic Materials and Indications. Advances in Respiratory Medicine. 2025;93(5):35. doi:10.3390/arm93050035
BibTeX
@article{Zitarska2025,
author = {Ziętarska, Anna and Dobek, Adam and Sawina, Anna and Białek, Piotr and Majewski, Sebastian and Stefańczyk, Ludomir},
title = {Bronchial Artery Embolisation in Haemoptysis Management: A Scoping Review with Emphasis on Embolic Materials and Indications},
journal = {Advances in Respiratory Medicine},
year = {2025},
volume = {93},
number = {5},
pages = {35},
doi = {10.3390/arm93050035}
}
EUVIMED